Drug Search Results
More Filters [+]

Troleandomycin

Alternative Names: troleandomycin, tao
Latest Update: 2024-12-11
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Bacterial Growth Inhibitor,Protein Synthesis Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Approved

Approved Countries: Australia | Chile | India | Italy | Malaysia | New Zealand | Portugal | Taiwan | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Shanghai Jiao Tong University School of Medicine
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Troleandomycin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ChiCTR2400094162

N/A

Not yet recruiting

Unknown

2028-12-31

ChiCTR2300067260

N/A

Not yet recruiting

Hypertension

2026-03-31

ChiCTR2300070608

N/A

Recruiting

Other

2025-08-31

ChiCTR2300070642

N/A

Recruiting

Brain Diseases|Inflammation

2025-06-30

Recent News Events

Date

Type

Title